We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$101M
AUM Growth
-$5.85M
Cap. Flow
-$5.14M
Cap. Flow %
-5.08%
Top 10 Hldgs %
21.62%
Holding
62
New
–
Increased
7
Reduced
53
Closed
–

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$349K
2
ENB icon
Enbridge
ENB
+$315K
3
JPM icon
JPMorgan Chase
JPM
+$247K
4
PRU icon
Prudential Financial
PRU
+$246K
5
GD icon
General Dynamics
GD
+$134K

Top Sells

Rank Stock Value
1
UL icon
Unilever
UL
+$519K
2
AVGO icon
Broadcom
AVGO
+$489K
3
MRK icon
Merck
MRK
+$433K
4
SNA icon
Snap-on
SNA
+$280K
5
GILD icon
Gilead Sciences
GILD
+$134K

Sector Composition

Rank Sector Weight
1 Financials 21.04%
2 Healthcare 15.17%
3 Industrials 11.33%
4 Technology 9.83%
5 Energy 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVGO icon
1
Broadcom
AVGO
$1.82T
$2.53M 2.5%
29,210
-6,860
-19% -$489K
AMP icon
2
Ameriprise Financial
AMP
$46.8B
$2.27M 2.24%
6,836
-427
-6% -$131K
SNA icon
3
Snap-on
SNA
$20.9B
$2.23M 2.21%
7,749
-1,082
-12% -$280K
LOW icon
4
Lowe's Companies
LOW
$116B
$2.23M 2.21%
9,891
-609
-6% -$127K
ITW icon
5
Illinois Tool Works
ITW
$81.4B
$2.2M 2.17%
8,780
-554
-6% -$130K
MSFT icon
6
Microsoft
MSFT
$2.84T
$2.14M 2.11%
6,282
-385
-6% -$121K
GILD icon
7
Gilead Sciences
GILD
$161B
$2.1M 2.08%
27,273
-1,680
-6% -$134K
IPG
8
DELISTED
Interpublic Group of Companies
IPG
$2.08M 2.06%
53,910
-3,236
-6% -$122K
ORI icon
9
Old Republic International
ORI
$10.3B
$2.05M 2.02%
81,303
-5,010
-6% -$125K
GPC icon
10
Genuine Parts
GPC
$17.1B
$2.04M 2.01%
12,031
-747
-6% -$122K
AFL icon
11
Aflac
AFL
$63.9B
$2.03M 2.01%
29,142
-1,796
-6% -$120K
NXST icon
12
Nexstar Media Group
NXST
$5.6B
$2.02M 2%
12,149
-744
-6% -$123K
JPM icon
13
JPMorgan Chase
JPM
$939B
$1.97M 1.94%
13,512
+1,799
+15% +$247K
OGE icon
14
OGE Energy
OGE
$10.3B
$1.92M 1.9%
53,385
-3,268
-6% -$120K
PSX icon
15
Phillips 66
PSX
$82.9B
$1.91M 1.89%
20,072
-1,232
-6% -$120K
PRU icon
16
Prudential Financial
PRU
$41.7B
$1.91M 1.89%
21,701
+2,945
+16% +$246K
GD icon
17
General Dynamics
GD
$105B
$1.88M 1.86%
8,740
+619
+8% +$134K
TXN icon
18
Texas Instruments
TXN
$255B
$1.86M 1.84%
10,332
-628
-6% -$108K
CVX icon
19
Chevron
CVX
$388B
$1.84M 1.82%
11,690
-719
-6% -$115K
MRK icon
20
Merck
MRK
$324B
$1.84M 1.82%
15,916
-3,811
-19% -$433K
LMT icon
21
Lockheed Martin
LMT
$134B
$1.84M 1.82%
3,989
-250
-6% -$116K
ENB icon
22
Enbridge
ENB
$124B
$1.83M 1.81%
49,263
+8,253
+20% +$315K
SCHW
23
Charles Schwab
SCHW
$177B
$1.83M 1.81%
32,292
-2,152
-6% -$113K
TD icon
24
Toronto Dominion Bank
TD
$198B
$1.83M 1.81%
29,490
+1,088
+4% +$65.5K
LYB icon
25
LyondellBasell Industries
LYB
$19.5B
$1.82M 1.8%
19,797
-1,247
-6% -$114K
1
2 3

Similar funds

EW
Expressive Wealth Chicago, Illinois $105M AUM
AFG
Artesa Financial Group Conroe, Texas $105M AUM
ANBOT
American National Bank of Texas Richardson, Texas $105M AUM
P
Palladiem Bryn Mawr, Pennsylvania $105M AUM
SPW
Signet Private Wealth Chicago, Illinois $105M AUM
SHF
Safe Harbor Fiduciary Pensacola, Florida $105M AUM
NS
Northland Securities Minneapolis, Minnesota $105M AUM
ACA
Alpha Capital Advisors Bangor, Maine $105M AUM

Weaver C. Barksdale & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Weaver C. Barksdale & Associates held 62 positions worth $101M, down 5.5% from $107M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Weaver C. Barksdale & Associates withdrew a net $5.14M in Q2 2023, reducing 53 holdings. Its largest reduction was Unilever, cutting an estimated $519K.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Weaver C. Barksdale & Associates added an estimated $349K to Pfizer.

  • Weaver C. Barksdale & Associates added most to Pfizer in Q2 2023, an estimated $349K increase.
  • Weaver C. Barksdale & Associates's biggest Q2 2023 reduction was Unilever, cutting an estimated $519K.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 22% of its $101M portfolio in Q2 2023.
  • Weaver C. Barksdale & Associates opened 0 new positions and closed 0 in Q2 2023.
  • Weaver C. Barksdale & Associates's portfolio value fell 5.5% quarter-over-quarter to $101M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2023, filed 14 Aug 2023.